Whole Exome Sequencing Market Worth $884.1 Million by 2018 - New Report by MarketsandMarkerts

The global whole exome sequencing market is categorized into five broad segments, namely, products and services, technologies, applications, end users, and geography (http://www.marketsandmarkets.com/Market-Reports/whole-exome-sequencing-market-107180258.html).

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
MarketsandMarkets

MarketsandMarkets

Thermo Fisher Scientific, Inc.) (U.S.), Roche NimbleGen, Inc. (U.S.), Agilent Technologies (U.S.), BGI (Beijing Genomics Institute, China), Eurofins Genomics, Inc. (Germany), Sengenics (U.S.)

(PRWEB) August 26, 2014

The “Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018” analyzes and studies the major market drivers, threats, opportunities, and challenges.

Browse 80 market data tables and 26 figures spread through 220 pages and in-depth TOC on "Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018"
http://www.marketsandmarkets.com/Market-Reports/whole-exome-sequencing-market-107180258.html

Early buyers will receive 10% customization on this report.

This report studies the global Whole Exome Sequencing (WES) market over the forecast period of 2013–2018. This market was valued at $326.6 million in 2013 and is poised to grow at a CAGR of 22%, to reach $884.1 million by 2018.

For More Inquiries @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=107180258

The global whole exome sequencing market is segmented on the basis of technology, products and services, applications, end users, and geography. Based on technology, the whole exome sequencing market is divided between sequencing by synthesis and sequencing by ion semiconductor. Based on products and services, the whole exome sequencing market comprises instruments/platforms/sequencers, kits, sequencing services and data analysis services. Whole exome sequencing kits are further classified into DNA fragmentation, end repair, A-Tailing and size selection, library preparation kits and target enrichment kit.

Ask for PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=107180258

Based on applications, the whole exome sequencing market is segmented into diagnostics, drug discovery and development, personalized medicine, and agriculture and animal research, among others. The market, by end users, is classified into research centers, academic and government institutions, hospitals and clinics, and pharmaceutical and biotechnology companies.

Based on geography, the market is divided into North America, Europe, Asia, and Rest of the World (RoW). North America is the largest market for whole exome sequencing, followed by Europe and Asia. The Asian market is slated to grow at the highest rate over the next five years.

Over the years, the demand for whole exome sequencing instruments, kits and services is likely to increase. Factors such as the rapidly decreasing costs of sequencing, adoption of WES technology by new consumers, strategic alliances amongst key players and research institutes, and increase in utilization of WES technology for new scientific applications are driving this demand for whole exome sequencing. The most important factor increasing the preference of WES over whole genome sequencing is its low-cost sequencing capability. However, a lack of skilled professionals and high reliability on government grants are some of the factors hindering the growth of the WES market.

Major players in the global whole exome sequencing market include Illumina, Inc. (U.S.) Life Technologies (acquired by Thermo Fisher Scientific, Inc.) (U.S.), Roche NimbleGen, Inc. (U.S.), Agilent Technologies (U.S.), BGI (Beijing Genomics Institute, China), Eurofins Genomics, Inc. (Germany), Sengenics (U.S.), GENEWIZ, Inc. (U.S.), Knome, Inc. (U.S.), Macrogen, Inc. (South Korea), and Ambry Genetics (U.S.), among others.

Browse Related Reports:
Digital Pathology Market by Slide Scanners (Whole Slide Imaging), Analytics (Image Analysis Software), Delivery Modes (Web Based/Cloud Based) & by Whole Slide Image Storage - Global Forecasts & Trends to 2018
http://www.marketsandmarkets.com/Market-Reports/digital-pathology-market-844.html

Genomics Market by Products - [Instruments (NGS platform, Microarray, RT-PCR), Consumables (Genechips, Reagents for DNA Extraction & Purification, Sequencing)], Services (Sequencing & Microarray Services, and Software) - Global Forecast to 2018
http://www.marketsandmarkets.com/Market-Reports/genomics-market-613.html

About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets


Contact